How to Follow, Manage and Treat Cardiac Dysfunction in Patients With Her2+ Breast Cancer

JACC CardioOncol. 2020 Nov 17;2(4):661-665. doi: 10.1016/j.jaccao.2020.08.010. eCollection 2020 Nov.

Authors

Anne Blaes¹, Charlotte Manisty², Ana Barac³

Affiliations

¹ University of Minnesota, Division of Hematology/Oncology, Minneapolis, Minnesota, USA.
² University College London and Barts Health NHS Trust, Division of Cardiology, London, United Kingdom.
³ MedStar Heart and Vascular Institute, Cardio-Oncology Program, Georgetown University, Washington, DC, USA.

No abstract available

Keywords: HER2 targeted therapy; LV dysfunction; breast cancer; cardiotoxicity; heart failure; trastuzumab.

Publication types

Review